Evidence map›Paper›PMID 31545855›Full record

ReviewInternational journal of pharmaceutics: X2019

Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: Lessons from non-protein charged colloids.

Jinjiang Li, Yuan Cheng, Xiaodong Chen, Songyan Zheng

Abstract readReview
In one paragraph

Review in International journal of pharmaceutics: X, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinjiang LiDrug Product Science & Technology, Bristol-Myers Squibb Corporation, 1 Squibb Dr., New Brunswick, NJ 08903, United States.
Yuan ChengDiscovery Pharmaceutics and Analytical Sciences, Bristol-Myers Squibb Corporation, 3551 Lawrenceville Princeton, Lawrence Township, NJ 08648, United States.
Xiaodong ChenDrug Product Science & Technology, Bristol-Myers Squibb Corporation, 1 Squibb Dr., New Brunswick, NJ 08903, United States.
Songyan ZhengDrug Product Science & Technology, Bristol-Myers Squibb Corporation, 1 Squibb Dr., New Brunswick, NJ 08903, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subcutaneous delivery of highly concentrated protein formulations is paramount for reducing healthcare cost and improving patient compliance, where reducing the solution viscosity of formulations is critical for drug delivery. The objective of this paper is to provide some mechanistic understanding about the contribution of electrostatic repulsion to the viscosity of protein solutions at high concentrations, along with the effect of excipients such as salts on relative viscosity. Proteins are treated as charged colloids in this paper. At high concentrations, the electrical double layer starts to overlap, and secondary electroviscous effect becomes significant in addition to primary electroviscous effect. In other words, the hydrodynamic volume of proteins plays a great role in influencing their solution viscosity because of the excluded volume effect. Currently, it is hypothesized that the high viscosity of concentrated protein solutions is attributed to formation of clusters due to either electrostatic attraction or hydrophobic interactions, especially for monoclonal antibodies, in which anybody molecules in high concentration formulations may form networks. Consequently, viscosity reduction in the presence of inorganic or organic salts in these formulations is due to breaking up of these networks. In this review, authors hope to provide another point of view based on the effect of the electrostatic repulsion on the excluded volume-hydrodynamic volume. Finally, authors hope the proposed theoretical framework can be used to guide excipient selection in the product development of highly concentrated proteins.

Indexed as

Drug deliveryElectrostatic interactionElectroviscous effectHigh concentrationProtein formulationsSubcutaneous injectionViscosity

Identifiers

PMID31545855
PMCPMC6733305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.